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Abstract 
The regulation of plasma membrane L-arginine transport activity was investigated in differentiated and undifferentiated states of the 
human intestinal cell line, Caco-2. The sodium-independent, leucine-insensitive uptake of L-arginine measured in this study has been 
assigned by us previously to system y+ in Caco-2 cells. Treatment of cells with serum-free media containing epidermal growth factor 
(EGF), transforming rowth factor ~ (TGFc~), or the protein kinase C (PKC) activator 12-O-tetradecanoylphorbol 13-acetate (TPA), 
stimulated system y + arginine transport activity in Caco-2 cells. Transport upregulation by these growth factors or by TPA was blocked 
by cycloheximide or the PKC inhibitor chelerythrine. Arginine uptake was diminished uring the course of differentiation, attributable to
a reduction in the transport system y+ capacity (Vma x) with no change in apparent affinity (K m). TPA stimulated arginine uptake required 
at least 3 h of continual exposure, and increased the membrane's transport capacity (Vrnax) in both undifferentiated and differentiated 
cells. TPA elevated the diminished transport Vma x of differentiated cells TPA to the elevated Vma x value associated with undifferentiated 
cells. We conclude that upregulation of arginine transport is part of a pleiotropic response to EGF/TGFa, and that this involves PKC and 
de novo synthesis of polypeptides associated with system y+ transport activity. 
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1. Introduction 
Following the recent discoveries of putative regulatory 
subunits of nutrient ransport systems, interest has surged 
regarding the cellular control of membrane transporters 
serving arginine and related metabolic intermediates [1-5]. 
Although it has been postulated that epithelial cells can 
modify their ability to transport amino acids [2,6-9], the 
cellular mechanisms are unknown. 
The intestinal epithelium is a rapidly renewing tissue 
exhibiting high rates of cell proliferation (hyperplasia) nd 
growth (hypertrophy). As proliferating epithelial cells arise 
from the crypt stem cells, they modify their plasma mem- 
brane capacity to transport certain nutrients required for 
acute cell growth [10]. Arginine and other conditionally 
essential amino acids are among such nutrients [11,12]. 
The present study was initiated because little is known 
regarding the signals involved in the regulation of epithe- 
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lial membrane amino acid transport [6,13-17]. We previ- 
ously demonstrated [8] that glutamine transport was upreg- 
ulated in intestinal epithelial apical membranes i olated 
from rats injected with epidermal growth factor (EGF). 
EGF and its analogue, transforming rowth factor a 
(TGFa), stimulate normal and malignant epithelial cells 
[18-21]. These growth factors are mucosal paracrines up- 
plied to the rapidly proliferating undifferentiated crypt 
cells by adjacent paneth cells [22,23]. EGF is also abun- 
dant in the intestinal umen, supplied orally primarily by 
the submaxillary salivary glands, and intestinally by Brun- 
ner's glands and pancreaticobiliary secretions [19,24]. Food 
sources, especially milk (10-400 ng/ml  EGF), supply 
exogenous EGF which is stable in the presence of gastric 
acid and digestive enzymes [18,22,25]. EGF and TGFa 
likely mediate effects through cellular kinases, including 
the protein kinase C family (PKC) and various oncogene 
products [19,26]. 
Regulation mechanisms are completely unknown con- 
cerning the transport of arginine and related metabolic 
intermediates associated with epithelial cell growth and 
proliferation. In this study we investigated the role of EGF 
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and regulators of PKC in modulating arginine transport via 
system y+ in Caco-2 cells. System y+ is a major trans- 
porter selective for arginine, lysine, and ornithine uptake in 
most cell types, and has been kinetically characterized by 
us in Caco-2 cells [27,29]. Caco-2 is an established cell 
line derived from a human colon adenocarcinoma, and is 
widely used as a model to study transport phenomena 
[30-33]. Newly passaged undifferentiated Caco-2 cells 
undergo spontaneous enterocytic differentiation after the 
culture attains confluence [33,34]. A preliminary account 
of a portion of this work has been presented elsewhere 
[27,281. 
2. Materials and methods 
2.1. Materials 
Dulbecco's modified Eagle's medium (DMEM), fetal 
bovine serum, sodium bicarbonate, penicillin, strepto- 
mycin, non-essential amino acids, trypsin, ethylene- 
diaminetetraacetic a id (EDTA), dimethyl sulfoxide 
(DMSO), Hepes, (N-(2-hydroxyethyl)piperazine-N'-(2- 
ethanesulfonic acid), tris(hydroxymethyl)aminomethane 
were of the highest grade from Sigma, St. Louis, MO. The 
0.2 /~M filters used to sterilize media were from Millipore, 
Bedford, MA. L-[3H]Arginine was obtained from Amer- 
sham, Arlington Heights, IL. Liquiscint scintillation fluid 
was from National Diagnostics, Atlanta, GA. The protein 
assay reagent was from Bio-Rad Lab, Richmond, CA. The 
established human intestinal epithelial cell line Caco-2 was 
initially obtained as passage #16 from American Type 
Culture Collection, Rockville, MD. The cells were cultured 
in 6-well tissue culture dishes (Falcon type 3046), or 100 
mm tissue culture dishes (Falcon type 3003). EGF and 
TGFc~ were human recombinant peptides obtained from 
Promega, Madison, WI, and were prepared from concen- 
trated stocks in 0.1 M acetic acid. Chelerythrine chloride 
was obtained from LC Services Corporation, Woburn, 
MA. All other reagents were obtained from Sigma. 
i! 2. Caco-2 cell cultures 
'i~co-2 stocks (passages #19-#40)  stored in liquid 
nitrogen were harvested from 100 mm Falcon tissue cul- 
ture dishes containing 15 ml of DMEM, 4.5 g/1 glucose, 
0.584 g/ l  glutamine, 10% fetal bovine serum, 3.7% sodium 
bicarbonate, 100 IU/ml penicillin, 100 /xg/ml strepto- 
mycin, and 1% non-essential mino acids [6,34]. Cells 
were grown in a humidified incubator at 37°C in 10% 
CO2/90% 0 2. The day of seeding was designated as day 
0. 
Caco-2 cells were subcultured by washing with 37°C 
isotonic calcium-free saline solution containing 0.05% 
trypsin and 0.02% EDTA, and flooding the dish with 10 
ml of the same solution for 5 min. The cell/trypsin 
mixture was dispersed with a narrow tip glass pipette, then 
added to DMEM containing 10% FBS. The dispersed cells 
were sedimented in a sterile conical centrifuge tube at 
1000 × g for 5 min, and the supernatant was removed. 
Next, growth medium was added to re-suspend the cells 
(using a narrow tip glass pipette) until cells were sepa- 
rated. Cell clumps were allowed to settle for a few min at 
1 × g, and only the top layer of medium containing single 
cells was used for sub-culturing, as confirmed by phase 
contrast microscope xamination. Cells were seeded at a 
cell density of 4.5 • 10  6 cells per 100 mm dish for future 
sub-culturing, or seeded in the 6-well cluster Falcon tissue 
culture dishes at a density of 3.86. 105 cells per 35 mm 
well for transport experiments. All cell culture solutions 
were filter-sterilized (0.2 /xm membrane filter) or/and 
autoclaved. The growth medium was changed daily, and 
cultures were inspected aily using a phase contrast micro- 
scope. 
2.3. Arginine uptake measurements 
Uptake of arginine was measured in cells two days 
post-seeding (undifferentiated) through 14 days post-seed- 
ing (differentiated). Cultures attained confluence at about 
day 6. Studies designed to compare transport in cells two 
days post-seeding and 9 days post-seeding, were conducted 
using cells started from the same seeding parent cells. 
System y+ transporter activity was measured at room 
temperature (23°C___ 1.0°C). System y+ is defined as 
sodium-independent, I 0 mM leucine-insensitive uptake of 
L-[3H]arginine, as described in Caco-2 by us [2,29]. Fol- 
lowing pre-treatment of cells with various agents (de- 
scribed below), the medium was aspirated, and cells were 
rinsed three times with uptake buffer (23°C) containing 
137 mM choline chloride, 10 mM Hepes/Tris buffer (pH 
7.4), 4.7 mM KCI, 1.2 mM MgSO 4, 1.2 mM KH2PO 4, 
and 2.5 mM CaC12. The uptake was initiated by adding 1 
ml uptake buffer containing L-[3H]arginine (2 /xCi/ml, 
0.5/xM to 1 mM unlabeled arginine) and 10 mM L-leucine. 
Culture dishes were continuously shaken by an orbital 
shaker (1 Hz) during the uptake period. Uptake was ar- 
rested by aspirating the uptake buffer, and washing three 
times with ice-cold buffer lacking substrate. Radioactivity 
of isotope extracted from the cells with 1 ml 1 M NaOH 
was neutralized with acetic acid, then assayed by liquid 
scintillation spectrometry. Protein in the NaOH extract was 
measured using the Bio-Rad protein assay. Initial rates of 
system y÷ transport activity were determined uring the 
linear uptake period (2 min), with zero time points serving 
as blanks [29]. Uptake rates are expressed as moles argi- 
nine per minute per mg cell protein. 
2.4. Treatments 
To treat cells with various agents (EGF/TGFc~, cyclo- 
heximide, chelerythrine, phorbol esters), growth medium 
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was first replaced with serum-free media (i.e., DMEM 
containing non-essential amino acids, penicillin and 
streptomycin, but lacking fetal bovine serum) for 2 h at 
37°C in the humidified incubator. The cells were then 
exposed to each agent at various times and concentrations 
described below. Pretreatment buffers were removed and 
replenished every 6 h. Caco-2 cells remained healthy 
(viability > 99% by dye exclusion) during at least 24 h of 
exposure to serum-free media. 12-O-Tetradecanoylphorbol 
13-acetate (TPA) and phorbol 12,13-dibutyrate were pre- 
pared from DMSO stocks, giving < 0.5% DMSO in final 
media exposed to cells. This concentration of DMSO did 
not influence uptake. 
2.5. Statistical analysis 
All experiments were conducted at least in triplicate 
(including the zero-time blanks), and all experiments were 
confirmed using at least two independently passaged gen- 
erations of cells. Experimental means are reported _ S.E. 
Comparisons of means were made by ANOVA with pair- 
wise multiple comparisons by the Newman-Keuls method 
at P < 0.05. Transport kinetic parameters were obtained 
by fitting data to the Michaelis-Menten equation by non- 
linear regression analysis [6,7] using the Enzfitter com- 
puter program (Biosoft, Cambridge, UK). 
3. Resu l ts  
3.1. Effect of EGF and TGFce on system y + activity 
Caco-2 cells two days post-seeding were exposed to 
EGF (100 ng/ml), TGFa (20 ng/ml), glucagon (2 
/~g/ml), or insulin (1 /zg/ml) in serum-free medium for 
12 h continuously. The data of Fig. ! demonstrated that 
TGFa and EGF each significantly stimulated system y+ 
activity compared to controls (P  < 0.05). Uptake of argi- 
nine in cells treated with either insulin or glucagon were 
not significantly different from controls (P  > 0.05; data 
not shown). 
3.2. Effect of chelerythrine and cycloheximide on growth 
.factor stimulation 
Inclusion of 20 /~M cycloheximide or 6.6 /xM chelery- 
thrine [35,36] in the serum-free treatment media containing 
TGFa or EGF blocked the stimulatory effect of the growth 
factors, as demonstrated in Fig. 1. In an independent set of 
experiments, we confirmed previous observations in Caco-2 
cells that [3H]thymidine incorporation and protein synthe- 
sis were each stimulated by EGF, and were inhibited by 
cycloheximide [3!,32]. In cycloheximide-treated cultures, 
the accumulated moles of arginine, protein content and the 
absolute numbers of cells in the dishes were each reduced 
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Fig. 1. System y+ uptake of 5 IzM t,-arginine in Caco-2 cultures (2 days 
post-seeding). Prior to measuring transport activity, cells were exposed 
continually for 12 h to DMEM media lacking fetal bovine serum, 
containing 100 ng/ml EGF, 20 ng/ml TGFa, 100 nM TPA, 20 p,M 
cycloheximide, and/or 6.6 /zM chelerythrine chloride. Each point repre- 
sents mean + S.E of 3-7 determinations. 
3.3. Effect of phorbol ester, cycloheximide or chelerythrine 
on system y + activity 
Caco-2 cells were incubated in serum-free medium with 
100 nM TPA with and without 20 /~M cycloheximide, 
and/or 6.6 IzM chelerythrine chloride during a 12 h 
period prior to measuring arginine uptake. The data of Fig. 
1 indicated that system y+ transport activity was stimu- 
lated by TPA, and that simultaneous incubation with chel- 
erythrine or cycloheximide blocked the TPA stimulation. 
Chelerythrine by itself did not influence arginine transport. 
3.4. Time-course of phorbol ester stimulation of arginine 
transport 
Caco-2 cells were continually incubated with 100 nM 
TPA in serum-free medium for various times ranging from 
0-24 h prior to measuring arginine uptake. The data of 
Fig. 2 shows that system y+ activity was stimulated 
following a 3 h exposure to 10 nM TPA, and that continual 
exposure to TPA stimulated transport activity throughout a 
24 h exposure period. The inset shows that TPA exposures 
up to 60 rain did not influence arginine transport. Similar 
results were obtained using 500 nM TPA or phorbol 
12,13-dibutyrate (data not shown). When cells were ex- 
posed to a 2 min pulse of TPA followed by a 12 h 
incubation in the same serum-free medium lacking TPA, 
the uptake rates subsequently measure at 12 h were not 
significantly different from the control rates (data not 
shown). 
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Fig. 2. Time-course of phorbol ester (TPA) stimulation of system y+ 
activity. Caco-2 cells (2 days post-seeding) were continuously incubated 
for various times in serum-free media containing 100 nM TPA (0 )  or 
lacking TPA ([]) prior to assaying 5 /xM arginine uptake via system y+. 
The inset shows exposure periods during the 60 min. Each point repre- 
sents mean + S.E of three determinations. TPA treated and control cells 
were from the same seeding eneration• 
3.5. Differentiation (cell age)-dependent phorbol ester 
stimulation of system y + activity 
We have shown elsewhere [27,29] that Caco-2 system 
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Fig. 3. Differentiation (cell age)-dependent phorbol ester stimulation of 
system y+ activity. Cells were exposed to serum-free media containing 
100 nM TPA (0 )  or lacking TPA (D)  for a 24 h period prior to assaying 
5 /xM arginine uptake via system y+. The confluent monolayer was 
attained on day 6. All cells were from the same passaged generation in 
this example; data were confirmed with three individually passaged 
cultures. Each point represents mean_+ S.E of three determinations. 
saging, with greater ates of uptake in undifferentiated 
cells (2 days post-seeding) dropping off and leveling after 
the cells formed a confluent monolayer and become differ- 
entiated (> day 6 post-seeding). The data of Fig. 3 con- 
firm this observation and further demonstrated that treat- 
ment with 100 nM TPA for 24 h in serum-free medium 
stimulated system y+ activity regardless of cell differentia- 
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Fig. 4. Eadie-Hofstee plot (u vs. z/[Arg]) of system y+ arginine transport kinetics measured in undifferentiated (2 days post-seeding) and confluent, 
differentiated (9 days post-seeding) cells. Cells were exposed to serum-free media containing or lacking TPA for 24 h prior to measuring system y+ 
arginine initial uptake rates at various arginine concentrations. Data were obtained for this figure using cells from the same seeding eneration, and the data 
were confirmed in cells from a different passage number. Points represent means _+ S.E of three determinations. Kinetic constants were obtained by 
non-linear regression analysis, as described in the text. 
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3.6. The effect of  phorbol ester on system y + transport 
kinetics 
Caco-2 cells were pre-treated with 500 nM TPA in 
serum-free medium for 24 h prior to measuring system y+ 
transport kinetics over the arginine concentration range of 
0.5 /.tM-l.0 mM. As shown in the Eadie-Hofstee kinetic 
plot of Fig. 4, for cells grown in serum-free media, the 
system y÷ capacity was greater in the undifferentiated 
state (cells 2 days post-seeding; Vma X = 777 + 14 pmol 
min- l mg protein- ~, K m = 44 +/.tM arginine) compared 
to the confluent and differentiated state (9 days post-seed- 
ing; Vma x = 542 + 32 pmol rain l mg protein- l, Km= 55 
_+ 5 /xM). Furthermore, the data of Fig. 4 indicated that 
inclusion of TPA in serum-free media stimulated the sys- 
tem y+ Vma ~ in day 2 cells (Vma x = 1174 _+ 64 pmol min 
mg protein -j , K m = 56-t-5 / xM) ,  and in day 9 cells 
(Vm~ × = 877 +_ 22 pmol min -j mg protein 1, K m = 43 _+ 2 
/xM). 
4. Discussion 
EGF, TGFc~, and phorbol ester can each stimulate 
epithelial cell growth and division [19,20]. Experiments 
with intact intestine and cultured epithelial cells suggest 
that EGF and TGFo~ influence the synthesis and expression 
of selected cell products, rather than simply non-specifi- 
cally stimulating protein synthesis [32]. Our results with 
undifferentiated and differentiated Caco-2 cells (Figs. 1-4) 
indicated that upregulation of system y+ transporter activ- 
ity is part of a pleiotropic response to EGF/TGFo~. 
EGF and TGFc~ elicit their functions by binding to 
Caco-2 EGF receptors [13,23], instigating a cascade of 
intracellular phophorylation events. One of the metabolic 
consequences of EGF/TGFc~ binding to receptors is the 
elevation of 1,2-diacylglycerol (DAG), which can subse- 
quently activate protein kinases such as PKC. Phorbol 
ester tumor promoters uch as TPA can substitute for 
DAG, and directly activate intracellular PKC [19,26]. Fig. 
1 indicates that EGF, TGFo~, or phorbol ester individually 
stimulated Caco-2 system y+ activity, and that each of 
their effects was blocked by chelerythrine. Chelerythrine 
specifically inhibits the catalytic domain of PKC (IC50 = 
0.66 /.tM for PKC; 1C5o = 170 /.tM for protein kinase A; 
and IC50 > 100 /xM for all other protein kinases) [35,36]. 
In the light of the present results (Figs. 1-4), therefore, 
upregulation of Caco-2 system y+ is likely mediated 
through protein kinase C. 
The arginine transport activity stimulatory effects of 
EGF, TFGa, or TPA were also blocked following expo- 
sure to cycloheximide over several hours. TPA stimulation 
was observed only after 3 h of continual exposure (Fig. 2). 
Therefore, it is unlikely that growth factor/phorbol ester 
stimulation of transport involved rapid (min) post-transla- 
tional modifications uch as phosphorylation of existing 
transporter p otein. This finding is consistent with the lack 
of possible phosphorylation sites on putative y-  proteins 
[37]. It is likely that stimulation involved de novo protein 
synthesis, as discussed below. 
The upregulation of system y+ aids in delivering sev- 
eral nutrients that are associated with the rapid growth of 
undifferentiated pithelial cells. System y+ transporter is
responsible for uptake of lysine and ornithine, and the 
conditionally essential amino acid arginine, in either the 
intact intestinal epithelium or Caco-2 cells [2,3,16,29]. Our 
results (Figs. 3 and 4) indicated that TPA stimulated 
uptake by increasing the membrane's capacity (Vmax) tO 
transport arginine in both differentiated and undifferenti- 
ated cells. In Fig. 4, it is notable that in the day 9 cells, the 
depressed arginine transport Vma x normally associated with 
cells in the differentiated state [29] was restored by TPA to 
the elevated Vma x normally associated with undifferentiated 
cells. In a manner opposite to arginine transport in the 
present study, glucose or dipeptide secondary active trans- 
porter capacities are suppressed in undifferentiated Caco-2 
cells, and are increased when the cells differentiate [30,31]. 
Therefore, the differentiation-associated change in arginine 
transport (Figs. 3 and 4) is not simply a non-specific 
membrane phenomenon. 
The plasma membrane 'transport system' is defined as 
a functional, physiological entity composed of a trans- 
porter (carrier) polypeptide alone or in combination with 
regulatory proteins [4]. The observed upregulation of argi- 
nine uptake (Figs. 1-4) likely involved de novo synthesis 
of polypeptides associated with transport system y ~ activ- 
ity, because stimulation was cycloheximide-sensitive, was
time-dependent over the course of hours following an 
initial lag period, and involved an increase in membrane 
uptake capacity (Vm, x). Possible candidate polypeptides 
include y+ carriers, putative regulatory subunits, and/or 
unknown transcription factors. 
The present study was focused on the regulation of 
arginine transport activity via system y+, which is opera- 
tionally defined as sodium-independent, leucine-insensi- 
tive, NEM-sensitive uptake of t-arginine [1,2]. Recent 
evidence suggests that cationic amino acid functional 
transporters are comprised of at least a carrier polypeptide 
responsible for y+ activity (or variants uch as b °'÷, B °'+, 
y+L, b~) and perhaps putative regulatory subunit poly- 
peptides [1-5]. In our attempts to identify the carrier 
species responsible for Caco-2 system y+ activity, we 
have demonstrated the presence of CAT-1 7.9 kb mRNA 
in Caco-2 cells, and we did not detect ranscripts of the 
related CAT isoforms [1] using reverse transcriptase in
conjunction with the polymerase chain reaction [29]. We 
found [29] that steady-state l vels of CAT-I mRNA were 
uncorrelated with y+ activity, remaining relatively con- 
stant over the course of differentiation, despite the differ- 
entiation-associated dramatic hanges in system y+ activ- 
ity. It remains to be investigated whether peptide growth 
factors and protein kinase C play a role in possible transla- 
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t iona l / t ranscr ip t iona l  control of arginine transport  via con- 
trol of  regulatory polypept ide subunits in Caco-2 intestinal 
epithel ial  cells. 
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